Skip to main content
. 2009 Jan-Feb;29(1):4–14. doi: 10.4103/0256-4947.51816

Figure 1.

Figure 1

Serum alanine aminotransferase (mean, standard deviation) in patients with sustained virological response (n=66) and in those who relapsed after end-of-treatment response (n=30) at baseline, 24, 48, and 72 weeks ost-treatment. aP=.001 vs. viral relapses.